Země: Izrael
Jazyk: angličtina
Zdroj: Ministry of Health
ALPRAZOLAM
CTS CHEMICAL INDUSTRIES LTD, ISRAEL
N05BA12
TABLETS
ALPRAZOLAM 1 MG
PER OS
Required
CTS CHEMICAL INDUSTRIES LTD, ISRAEL
ALPRAZOLAM
ALPRAZOLAM
Treatment of symptoms of tension and anxiety, anxiety accompanied by depression and in panic states with or without phobia.
2023-10-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only ALPRALID TABLETS 0.25, 0.5, 1 MG ALPRALID 0.25: Each tablet contains: Alprazolam 0.25 mg ALPRALID 0.5: Each tablet contains: Alprazolam 0.5 mg ALPRALID 1: Each tablet contains: Alprazolam 1 mg Inactive ingredients and allergens in the preparation - see section 6 “Additional information” and the “Important information about some ingredients of the medicine” section. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any other questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. WHAT IS THE MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT ALPRALID? TAKING THIS MEDICINE TOGETHER WITH OPIOID MEDICINES, WITH OTHER MEDICINES THAT DEPRESS THE CENTRAL NERVOUS SYSTEM (INCLUDING DRUGS) OR WITH ALCOHOL, MAY CAUSE A SENSATION OF DEEP DROWSINESS, BREATHING DIFFICULTIES (RESPIRATORY DEPRESSION), COMA AND DEATH. INTRODUCTION TO THE CONSUMER LEAFLET FOR BENZODIAZEPINES THIS MEDICINE BELONGS TO THE BENZODIAZEPINES GROUP, WHICH HAS SPECIAL CHARACTERISTICS THAT REQUIRE EXTRA CARE DURING USE. - IT IS HIGHLY IMPORTANT TO BE UNDER CLOSE MEDICAL SUPERVISION WHEN TAKING THIS MEDICINE. - WHEN TAKING THIS MEDICINE, BE SURE TO REFER TO THE DOCTOR AFTER 2-4 WEEKS, SINCE THE TREATMENT IS ONLY INTENDED FOR SHORT TIME PERIODS. - PROLONGED USE OF THIS MEDICINE MAY CAUSE THE EFFECT OF THE MEDICINE TO DECREASE. PROLONGED USE MAY CAUSE SEVERE DEPENDENCY, MAKING IT DIFFICULT FOR THE PATIENT TO STOP TAKING THE MEDICINE. - UNCONTROLLED DISCONTINUATION OF THIS TREATMENT WILL BE ACCOMPANIED BY WITHDRAWAL EFFECTS, SUCH AS: STRESS, NERVOUSNESS, CONFUSION, TREMOR, INSOMNIA, ABDOMINAL PAIN, VOMITING, NAUSEA, SWEATING, SPASMS, CRAMPS AND MUSCLE PAIN. Přečtěte si celý dokument